EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetes

Jinhao Chen, Xiang Dong, Yichen Lin, Cunming Lv

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.155985 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Jinhao Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: China Three Gorges University, Yichang 443002, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University…. Hauptthemen laut MEDLINE: Parkinson Disease, Glucagon-Like Peptide 1, Signal Transduction, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 126 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review assesses the roles of GLP-1 and its receptor agonists (GLP-1RAs) in the treatment of diabetes and Parkinson's disease, integrating current theories and research. GLP-1, a vital endogenous hormone, regulates insulin secretion, delays gastric emptying, and promotes satiety, showing significant potential for diabetes management. However, its brief lifespan and restricted blood-brain barrier penetration limit its clinical application. To overcome these constraints, researchers have developed GLP-1 receptor agonists that prolong its action and exhibit high efficacy in diabetes treatment. Recent studies further reveal GLP-1's neuroprotective effects, notably its potential in managing neurodegenerative disorders such as Parkinson's disease. GLP-1RAs mitigate neuroinflammation, reduce oxidative stress, and enhance neuroprotection, suggesting substantial potential for treating neurodegenerative diseases. Additionally, to enhance GLP-1RAs' efficacy in the nervous system, researchers have introduced novel drug delivery approaches, including nanoparticle carriers and molecular modifications, to improve stability and targeting accuracy. In conclusion, this review comprehensively analyzes the mechanisms, clinical applications, and challenges of GLP-1 and its receptor agonists in managing diabetes and Parkinson's disease, while identifying future research and clinical opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGlucagon-Like Peptide 1Signal TransductionDiabetes MellitusHumansAnimalsGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

Blood-Brain BarrierDiabetesGLP-1NeuroprotectionParkinson’s Disease

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • China Three Gorges University, Yichang 443002, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, Hubei 443002, China; College of Basic Medical Sciences, Chi…
  • Ningbo University, Ningbo 315211, China.

Zitieren

APA

Chen, J., Dong, X., Lin, Y., & Lv, C. (2025). The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetes. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155985

Vancouver

Chen J, Dong X, Lin Y, Lv C. The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetes. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155985

BibTeX
@article{Chen2025,
  author = {Chen, Jinhao and Dong, Xiang and Lin, Yichen and Lv, Cunming},
  title = {The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetes},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.155985}
}
Kostenlos starten →